TRUBRIDGE INC(NASDAQ:TBRG) stock Fundamental Analysis

Fundamental Rating

TBRG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 39 industry peers in the Health Care Technology industry. TBRG may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, TBRG is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

TBRG had positive earnings in the past year.

TBRG had a positive operating cash flow in the past year.

Of the past 5 years TBRG 4 years were profitable.

In the past 5 years TBRG always reported a positive cash flow from operatings.

1.2 Ratios

With a decent Return On Assets value of -15.12%, TBRG is doing good in the industry, outperforming 64.86% of the companies in the same industry.

The Return On Equity of TBRG (-35.16%) is better than 62.16% of its industry peers.

		Industry Rank	Sector Rank
ROA	-15.12%
ROE	-35.16%
ROIC	N/A

ROA(3y)-0.66%

ROA(5y)1.61%

ROE(3y)-3.06%

ROE(5y)1.68%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TBRG has a Gross Margin (49.41%) which is in line with its industry peers.

In the last couple of years the Gross Margin of TBRG has declined.

TBRG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	49.41%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.19%

GM growth 5Y-2.03%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TBRG does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for TBRG has been increased compared to 1 year ago.

The number of shares outstanding for TBRG has been increased compared to 5 years ago.

Compared to 1 year ago, TBRG has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.18 indicates that TBRG is not a great score, but indicates only limited risk for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 2.18, TBRG is in the better half of the industry, outperforming 64.86% of the companies in the same industry.

TBRG has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 1.00, TBRG is not doing good in the industry: 81.08% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	1
Debt/FCF	N/A
Altman-Z	2.18

ROIC/WACCN/A

WACC10.09%

2.3 Liquidity

A Current Ratio of 1.80 indicates that TBRG should not have too much problems paying its short term obligations.

With a Current ratio value of 1.80, TBRG perfoms like the industry average, outperforming 59.46% of the companies in the same industry.

A Quick Ratio of 1.78 indicates that TBRG should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.78, TBRG is in line with its industry, outperforming 59.46% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.8
Quick Ratio	1.78

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for TBRG have decreased strongly by -75.49% in the last year.

Measured over the past years, TBRG shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.46% on average per year.

Looking at the last year, TBRG shows a very strong growth in Revenue. The Revenue has grown by 24.98%.

The Revenue has been growing slightly by 3.90% on average over the past years.

EPS 1Y (TTM)-75.49%

EPS 3Y-6.92%

EPS 5Y-6.46%

EPS Q2Q%-146.67%

Revenue 1Y (TTM)24.98%

Revenue growth 3Y8.67%

Revenue growth 5Y3.9%

Sales Q2Q%1.35%

3.2 Future

The Earnings Per Share is expected to grow by 5.37% on average over the next years.

Based on estimates for the next years, TBRG will show a small growth in Revenue. The Revenue will grow by 4.00% on average per year.

EPS Next Y-72.79%

EPS Next 2Y-5.54%

EPS Next 3Y5.37%

EPS Next 5YN/A

Revenue Next Year-0.65%

Revenue Next 2Y2.57%

Revenue Next 3Y4%

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 56.52 indicates a quite expensive valuation of TBRG.

TBRG's Price/Earnings ratio is a bit cheaper when compared to the industry. TBRG is cheaper than 78.38% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 29.63. TBRG is valued rather expensively when compared to this.

With a Price/Forward Earnings ratio of 17.69, TBRG is valued on the expensive side.

89.19% of the companies in the same industry are more expensive than TBRG, based on the Price/Forward Earnings ratio.

TBRG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	56.52
Fwd PE	17.69

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TBRG indicates a somewhat cheap valuation: TBRG is cheaper than 75.68% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	26.5

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-5.54%

EPS Next 3Y5.37%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for TBRG!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

TRUBRIDGE INC

NASDAQ:TBRG (2/21/2025, 8:00:01 PM)

After market: 28.43 +0.17 (+0.6%)

28.26

+0.34 (+1.22%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)02-18 2025-02-18/amc

Earnings (Next)05-08 2025-05-08/bmo

Inst Owners74.28%

Inst Owner Change0%

Ins Owners2.34%

Ins Owner Change0.49%

Market Cap421.92M

Analysts78.18

Price Target23.26 (-17.69%)

Short Float %2.72%

Short Ratio3.28

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-91.99%

Min EPS beat(2)-176.25%

Max EPS beat(2)-7.73%

EPS beat(4)2

Avg EPS beat(4)-39.74%

Min EPS beat(4)-176.25%

Max EPS beat(4)24.18%

EPS beat(8)4

Avg EPS beat(8)-25.4%

EPS beat(12)6

Avg EPS beat(12)-15.77%

EPS beat(16)8

Avg EPS beat(16)-10.97%

Revenue beat(2)1

Avg Revenue beat(2)0.05%

Min Revenue beat(2)-0.82%

Max Revenue beat(2)0.92%

Revenue beat(4)1

Avg Revenue beat(4)-0.71%

Min Revenue beat(4)-1.68%

Max Revenue beat(4)0.92%

Revenue beat(8)1

Avg Revenue beat(8)-1.49%

Revenue beat(12)4

Avg Revenue beat(12)-0.32%

Revenue beat(16)5

Avg Revenue beat(16)-0.86%

PT rev (1m)23.91%

PT rev (3m)86.89%

EPS NQ rev (1m)7.22%

EPS NQ rev (3m)33.1%

EPS NY rev (1m)-5.13%

EPS NY rev (3m)-41.23%

Revenue NQ rev (1m)0.04%

Revenue NQ rev (3m)-0.2%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.08%

Valuation

		Industry Rank	Sector Rank
PE	56.52
Fwd PE	17.69
P/S	1
P/FCF	N/A
P/OCF	44.24
P/B	2.44
P/tB	N/A
EV/EBITDA	26.5

EPS(TTM)0.5

EY1.77%

EPS(NY)1.6

Fwd EY5.65%

FCF(TTM)-0.7

FCFYN/A

OCF(TTM)0.64

OCFY2.26%

SpS28.19

BVpS11.56

TBVpS-8.09

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-15.12%
ROE	-35.16%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	49.41%
FCFM	N/A

ROA(3y)-0.66%

ROA(5y)1.61%

ROE(3y)-3.06%

ROE(5y)1.68%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.19%

GM growth 5Y-2.03%

F-Score6

Asset Turnover1.05

Health

		Industry Rank	Sector Rank
Debt/Equity	1
Debt/FCF	N/A
Debt/EBITDA	7.79
Cap/Depr	67.32%
Cap/Sales	4.76%
Interest Coverage	N/A
Cash Conversion	42.87%
Profit Quality	N/A
Current Ratio	1.8
Quick Ratio	1.78
Altman-Z	2.18

F-Score6

WACC10.09%

ROIC/WACCN/A

Cap/Depr(3y)77.47%

Cap/Depr(5y)59.31%

Cap/Sales(3y)5.5%

Cap/Sales(5y)3.93%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-75.49%

EPS 3Y-6.92%

EPS 5Y-6.46%

EPS Q2Q%-146.67%

EPS Next Y-72.79%

EPS Next 2Y-5.54%

EPS Next 3Y5.37%

EPS Next 5YN/A

Revenue 1Y (TTM)24.98%

Revenue growth 3Y8.67%

Revenue growth 5Y3.9%

Sales Q2Q%1.35%

Revenue Next Year-0.65%

Revenue Next 2Y2.57%

Revenue Next 3Y4%

Revenue Next 5YN/A

EBIT growth 1Y-466.73%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year26.84%

EBIT Next 3Y20.59%

EBIT Next 5YN/A

FCF growth 1Y-140.67%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-78.07%

OCF growth 3Y-72.17%

OCF growth 5Y-46.4%

TRUBRIDGE INC (TBRG) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens